[1] XU YJ, ZHAN XY, BAI ZF, et al.Exploring the Safety of Psoralea corylifolia and Strategies for its Rational Clinical Use Based on the Evolution of Efficacy/Toxicity Records in Ancient and Modern Literature[J]. Acta Pharmaceutica Sinica(药学学报), 2025, 60(2): 314-322. [2] JI B.Recent Advances in Modern Research on Psoralea corylifolia[J]. Guangming J Chin Med(光明中医). 2024, 39(24): 5075-5078. [3] ZHANG XY, WANG DN, CHAI X, et al.Analysis of Quality Characteristics of Psoralea corylifolia and Their Application in Detoxification Processes[J]. China Tradit Herb Drugs(中草药), 2024, 55(8): 2784-2791. [4] YANG YT, CHEN LL, YANG JJ, et al.Research Progress on Hepatotoxicity of Psoralea corylifolia and Compatibility-Based Detoxi-fication Mechanisms[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2025, 27(1): 84-90. [5] PAN ZY.Research Progress on Clinical Hepatotoxicity of Psoralea corylifolia[J]. Anti-Infection Pharmacology(抗感染药学), 2024, 21(9): 879-883. [6] GAO Y, WEI MM, WU SY, et al.Pharmacokinetic Characteristics of Psoralen, Isopsoralen, Psoralenoside and Isopsoralenoside in Rats after Oral Administration of Psoraleae Fructus Extract[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2021, 46(16): 4244-4251. [7] DONG XJ, LIU HM, QIAN WX, et al.Analysis of the Action Patterns of Reproductive Toxic Traditional Chinese Medicines Based on the System Toxicology Database of TCM[J]. China Journal of Reproductive Health(中国生育健康杂志), 2025, 36(2): 187-192. [8] TANG X, HAN JY, PAN C, et al.Experimental Studies and Network Toxicology Prediction on Liver Injury Induced by Psoralea corylifolia: Research Progress[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2024, 30(2): 179-189. [9] GUO ZJ, ZHANG JX, TU C, et al.Reflections on Several Issues Concerning Potential Hepatotoxicity of Traditional Chinese Medicine[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2020, 35(11): 5399-5402. [10] AO T, WANG NN, ZHOU L, et al.Confirmation and Mechanism of Psoralen-Induced Hepatotoxicity in Zebrafish Based on Clinical Medication Characteristics[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2024, 21(6): 611-616. [11] WANG J, ZHOU ZX, YANG L, et al.Establishment of UPLC Fingerprint of Psoralea corylifolia and Determination of 12 Major Components[J]. Chinese Traditional and Herbal Drugs(中草药), 2021, 52(2): 552-557. [12] SHI Z, PAN JC, ZHANG C, et al.Spectrum-Toxicity Relationship Study of Psoralea corylifolia and Its Classical Prescriptions[J]. Acup-uncture and Herbal Medicine, 2024, 4(2): 234-242. [13] ZHANG T, YANG JL, ZHU A, et al.Metabolic Stability and Gender Differences of Psoralen in Rat and Human Liver Microsomes Involving Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases[J]. Chinese Journal of Pharmacology and Toxicology(中国药理学与毒理学杂志), 2019, 33(5): 354-360. [14] LI JY, LIU XX, NING Q, et al.Efficient Identification of Toxicity-Related Component Groups of Psoralea corylifolia Based on Zebrafish Model[J]. Chinese Traditional and Herbal Drugs(中草药), 2021, 52(1): 129-136. [15] NIE F.Exploration of the Toxic Material Basis of Psoralea corylifolia Hepatotoxicity Based on Molecular Docking Simulation of Its Monomers with CYP1A2 Enzyme[J]. China Prescription Drug(中国处方药), 2025, 23(11): 10-13. [16] YANG Y, GUO G, ZHOU W, et al.Sestrin2 Protects against Bavachin Induced ER Stress through AMPK/mTORC1 Signaling Pathway in HepG2 Cells[J]. Journal of Pharmacological Sciences, 2021, 145(2): 175-186. [17] HUANG CS, DENG HF, ZHOU L, et al.Undesirable ER Stress Induced by Bavachin Contributed to Follicular Atresia in Zebrafish Ovary[J]. Biomed Pharmacother, 2023, 166: 115322. [18] ZHU CY.Hepatotoxicity of Psoralea corylifolia in Zebrafish with Pigment Loss[D]. Jinan: Qilu University of Technology (齐鲁工业大学), 2023. [19] XIA LL, CHEN Y, TANG SL, et al.Correlation between Psoralea corylifolia and Precocious Puberty in Children Based on Network Pharmacology[J]. Journal of Guangzhou University of Chinese Medicine(广州中医药大学学报), 2024, 41(4): 981-987. [20] LIN GT, LI RW, GENG ZK, et al.Comparison of Estrogen-Like Effects between Aqueous and Ethanol Extracts of Psoralea corylifolia[J]. Chinese Traditional Patent Medicine(中成药), 2016, 38(12): 2688-2691. [21] YANG K.Sex-Specific Liver Injury Induced by Psoralen and Isopsoralen and Serum Metabolomics Study[D]. Nanchang: Jiangxi University of Chinese Medicine, 2021. [22] LIU CY, TIAN JZ, YI Y, et al.Hepatotoxicity of Psoralea corylifolia L. (Buguzhi) Administration during Pregnancy in Maternal and Weaned Offspring Rats[J]. Science oF Traditional Chinese Medicine, 2025, 3(2): 168-177, 205. [23] LI ZJ, ABULIZI A, ZHAO GL, et al.Bakuchiol Contributes to the Hepatotoxicity of Psoralea corylifolia in Rats[J]. Phytotherapy Research, 2017, 31: 1265-1272. [24] XU YJ, ZHAN XY, BAI ZF, et al.Exploring the Safety of Psoralea corylifolia and Strategies for Rational Clinical Use Based on the Evolution of Efficacy/Toxicity Records in Ancient and Modern Literature[J]. Acta Pharmaceutica Sinica(药学学报), 2025, 60(2): 314-322. [25] MADEIRA C, COSTA PM.Proteomics in Systems Toxicology[J]. Advances in Protein Chemistry and Structural Biology, 2021, 127: 55-91. [26] BAUDIFFIER D, AUDOUZE K, ARMANT O, et al.Correction to: Editorial Trend:Adverse Outcome Pathway (AOP) and Computational Strategy - Towards New Perspectives in Ecotoxicology[J]. Environ Sci Pollut Res, 2025, 32(8): 4926. [27] LIU TT, CHANG FH, CHEN Q, et al.Research Progress in Systems Toxicology[C]//Chinese Pharmacological Society, Professional Committee of Safety Pharmacology. Proceedings of the 4th China Safety Pharmacology Annual Conference (2023). School of Pharmacy, Inner Mongolia Medical University; New Drug Screening Engineering Research Center of Inner Mongolia Autonomous Region; New Drug Safety Evaluation Research Center of Inner Mongolia Medical University, 2023: 107-108. [28] ZHOU ZC.Mode of Toxic Action and Adverse Outcome Pathway[J]. Chinese Journal of Toxicology(毒理学杂志), 2014, 28(1): 1-2. [29] VILLENEUVE DL, CRUMP D, GARCIA-REYERO N, et al.Adverse Outcome Pathway (AOP) Development I: Strategies and Principles[J]. Toxicol Sci, 2014, 142(2): 312-320. [30] HU Q, TONG Z, YALIKONG A, et al.DNAzyme-Based Faithful Probing and Pulldown to Identify Candidate Biomarkers of Low Abundance[J]. Nat Chem, 2024, 16(1): 122-131. [31] HUANG HH, XIAO YM.The Association between Mode of Action and Adverse Outcome Pathway and Its Application in Risk Assessment[J]. Chinese Journal of Preventive Medicine(中华预防医学杂志), 2020, 54(2): 219-223. [32] LAMBERT JC.Adverse Outcome Pathway 'Footprinting': a Novel Approach to the Integration of 21st Century Toxicology Information into Chemical Mixtures Risk Assessment[J]. Toxics, 2023, 11(1): 37. |